Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NGL FINE CHM   TEVA PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
TEVA PHARMA
Dec-13
NGL FINE CHM/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,5693,479-   
Low Rs1,1613,022-   
Sales per share (Unadj.) Rs450.01,996.4-  
Earnings per share (Unadj.) Rs33.2124.7-  
Cash flow per share (Unadj.) Rs51.4286.1-  
Dividends per share (Unadj.) Rs1.75109.18-  
Avg Dividend yield %0.13.4 2.8%  
Book value per share (Unadj.) Rs360.12,217.6-  
Shares outstanding (eoy) m6.18848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.6 254.5%   
Avg P/E ratio x56.226.1 215.7%  
P/CF ratio (eoy) x36.311.4 319.1%  
Price / Book Value ratio x5.21.5 353.3%  
Dividend payout %5.387.5 6.0%   
Avg Mkt Cap Rs m11,5232,756,220 0.4%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3690-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m2,7811,692,969 0.2%  
Other income Rs m550-   
Total revenues Rs m2,8361,692,969 0.2%   
Gross profit Rs m350463,620 0.1%  
Depreciation Rs m113136,844 0.1%   
Interest Rs m1833,253 0.1%   
Profit before tax Rs m274293,523 0.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m69-3,584 -1.9%   
Profit after tax Rs m205105,758 0.2%  
Gross profit margin %12.627.4 45.9%  
Effective tax rate %25.1-1.2 -2,055.2%   
Net profit margin %7.46.2 118.0%  
BALANCE SHEET DATA
Current assets Rs m1,6271,143,425 0.1%   
Current liabilities Rs m583997,163 0.1%   
Net working cap to sales %37.58.6 434.4%  
Current ratio x2.81.1 243.3%  
Inventory Days Days6591 71.8%  
Debtors Days Days86596 901.5%  
Net fixed assets Rs m1,244552,961 0.2%   
Share capital Rs m314,167 0.7%   
"Free" reserves Rs m2,1950-   
Net worth Rs m2,2251,880,567 0.1%   
Long term debt Rs m21865,653 0.0%   
Total assets Rs m2,8713,868,976 0.1%  
Interest coverage x15.99.8 162.0%   
Debt to equity ratio x00.5 2.0%  
Sales to assets ratio x1.00.4 221.4%   
Return on assets %7.83.6 216.5%  
Return on equity %9.25.6 163.8%  
Return on capital %13.04.9 263.6%  
Exports to sales %74.30-   
Imports to sales %9.90-   
Net fx Rs m1,7900-   
CASH FLOW
From Operations Rs m353269,772 0.1%  
From Investments Rs m-270-95,591 0.3%  
From Financial Activity Rs m-11-323,609 0.0%  
Net Cashflow Rs m72-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare NGL FINE CHM With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare NGL FINE CHM With: EVEREST ORGANICS  BDH INDUS.  VENUS REMEDIES  COLINZ LABOR  IND. SWIFT  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.